Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens

Table 9

The probability of side effects of ligands on human health.

Ligand	The probability of side effects ()
	Blood	Cardiovascular system	Gastrointestinal system	Kidney	Liver	Lung
Nova2 (9058064-6)	0.24	0.07	0.81	0.10	0.08	0.62
Nova2 (95752-88-8)	0.24	0.07	0.81	0.10	0.08	0.62
Nova2 (88765-82-6)	0.24	0.07	0.81	0.10	0.08	0.62
Nova2 (Unique10)	0.24	0.07	0.81	0.10	0.08	0.62
Nova2 (16876-27-0)	0.24	0.07	0.81	0.10	0.08	0.62
Nova2  (513246-99-6)	0.24	0.07	0.81	0.10	0.08	0.62
Nova2 (Unique80)	0.24	0.07	0.81	0.10	0.08	0.62
Nova2 (279262-23-6)	0.24	0.07	0.81	0.10	0.08	0.62
SAHA	0.36	0.25	0.07	0.11	0.11	0.37
TSA	0.59	0.50	0.51	0.27	0.52	0.63